Accomplished business leaders will advance mission of funding research and treatment options for rare pediatric cancers

Charlotte, NC – The Isabella Santos Foundation (ISF), a 501(c)(3) dedicated to advancing treatment options for rare pediatric cancers, proudly welcomes 12 distinguished professionals to its Board of Directors. This expansion will strengthen ISF’s mission and support the national reach of the TORCH Initiative (Transformational Outcomes for Rare Cancer Heroes), focused on improving both the quantity and quality of life for children facing rare cancers worldwide.

New members joining the ISF Board of Directors:

• Jennifer Bauer, Chief Marketing Officer, Second Nature Brands
• Jeff Boland, Director of Operations, Mac’s Speed Shop
• Donna Hargrove, General Counsel, Amwins
• Nathan Holbrook, Healthcare Group Leader, JE Dunn Construction
• Richard Jordan, VP of Strategic Partnerships, Red Ventures
• Rob Miller, President, Ram Pavement
• Carrie Sindelar, General Counsel, Honeywell International Inc.
• Scott Peterson, Chief Partnership Officer, Spiracle & Benefit Auctioneer, Custom Benefit Auctions
• Kate Puckett, Senior Vice President, Puckett LPL Financial
• Joey Pruitt, U.S. CFO, Hissho Sushi
• Charlie Stahler, CEO, National Safety and Risk
• Dana Mann, Director of Internal Audit, Krispy Kreme Doughnuts

These accomplished leaders bring diverse expertise spanning finance, legal, marketing, operations, and strategic partnerships. Their collective experience will be instrumental in advancing ISF’s $2 million annual funding goal for the TORCH Initiative, empowering the foundation to further fund life-changing research and survivorship support at pediatric hospitals across the Carolinas and beyond.

“We are so excited to welcome this incredible group of professionals to our board,” said Erin Santos Primis, Executive Director and Founder of ISF. “Their dedication and leadership will play a pivotal role in driving impact and ensuring we continue to make meaningful strides in the fight against rare pediatric cancers.”

These board member additions come at a pivotal time following the TORCH Initiative announcement, which builds on ISF’s 18-year legacy, leveraging community engagement and strategic partnerships to drive impactful change. This initiative aims to expand access to cutting-edge treatments and improve outcomes for children facing rare cancer diagnoses.

For more information about the Isabella Santos Foundation and how to support the TORCH Initiative, please visit isftorch.org.

# #

About the Isabella Santos Foundation:

Established in 2007, The Isabella Santos Foundation (ISF) is dedicated to eradicating pediatric cancer’s devastating impact while honoring the legacy of Isabella Santos, a courageous neuroblastoma fighter. Through the TORCH initiative, ISF provides funding for clinical trials, basic science and translational research, and survivorship support at medical institutions across North and South Carolina, igniting transformational outcomes for rare pediatric cancer heroes.

For nearly two decades, ISF has raised over $14 million to expand research and treatment and support affected families. Partnering with Atrium Health and Levine Children’s Hospital, ISF funded clinical trials, developmental therapeutics and a top-tier MIBG therapy suite—one of 20 nationwide. In 2020, the Isabella Santos Rare & Solid Tumor Program launched with Levine Cancer Institute, aspiring to be a global hub for children with solid tumors and rare cancers.

Originating from one girl’s mission, and carried forward by her loving mom, her family and the support of the Charlotte community, ISF’s impact thrives and its ability to transform lives will endure for generations. Join our commitment to bring hope, healing and progress to young pediatric cancer heroes and their families.

ISF Media Contact:
Anna Stallmann, media@annacomms.com